Cobalt-Induced Lung Injury and Hypoxia-Inducible Factor 1α

Toxicological Sciences, Nov 2010

Ken-ichiro Inoue, Masako Kiyono, Yuka Sone, Hirohisa Takano

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://toxsci.oxfordjournals.org/content/118/1/318.full.pdf

Cobalt-Induced Lung Injury and Hypoxia-Inducible Factor 1α

Ken-ichiro Inoue 1 2 Masako Kiyono 1 2 Yuka Sone 1 2 Hirohisa Takano 0 1 0 National Institute for Environmental Studies , Tsukuba 305-8506 , Japan 1 Guo , J., Lu, W., Shimoda, L. A., Semenza, G. L., and Georas, S. N. (2009). Enhanced interferon-gamma gene expression in T Cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1- alpha-deficient mice. Int. Arch. Allergy Immunol. 149, 98-102. Lee, K. S., Kim, S. R., Park, H. S., Park, S. J., Min, K. H., Lee, K. Y., Choe, Y. H., Hong, S. H., Han, H. J., Lee, Y. R. , et al. (2007). A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. Exp. Biol. Med. 39, 756-768. Saini, Y., Greenwood, K. K., Merrill, C., Kim, K. Y., Patial, S., Parameswaran, N., Harkema, J. R., and LaPres, J. J. (2010). Acute cobalt- induced lung injury and the role of hypoxia-inducible factor 1alpha in modulating inflammation. Toxicol. Sci. 116, 673-681. Sumbayev, V. V., Nicholas, S. A., Streatfield, C. L., and Gibbs, B. F. (2009). Involvement of hypoxia-inducible factor-1 HiF(1alpha) in IgE-mediated primary human basophil responses. Eur. J. Immunol. 39, 3511-3519 2 Department of Public Health and Molecular Toxicology, School of Pharmacy, Kitasato University , Tokyo 108-8641 , Japan - We read with great interest the in vivo study by Saini et al. (2010) characterizing cobalt-induced acute lung injury, which depends on hyoxia-inducible factor (HIF)1a. Their study apparently showed that HIF1a modulates the dominance of effector leukocytes in the inflamed lung (neutrophils vs. eosinophils) employing a genetic approach. However, we have some comments. At first, in Abstract, Saini et al. (2010) stated that cobaltexposed control mice showed neutrophilic inflammation with the induction of Th1 cytokines. However, in their results, the lung interferon-c level was not increased in these mice. On the other hand, although interleukin (IL)-2 was elevated by cobalt in both genotypes of mice, this cytokine shows a biphasic role in Th1/Th2 immunity. Rather, cobalt-treated control mice exhibited an early increase in the levels of tumor necrosis factor-a and IL-6, which is likely to be due to macrophage activation. Overall, it does not seem that cobalt exposure allowed the control lung to proceed to the Th1 milieu. Second, in Introduction and Discussion, they referred to the clinical entity cobalt asthma or asthma-like phenotype. However, in their study, Saini et al. (2010) examined neither lung function (airway responsiveness) nor airway smooth muscle cell characterization, particularly in HIF1aD/D mice. Mast cellmediated bronchoconstriction may be investigated in cobalt-inhaled mice in the future since HIF1a is implicated in mast cell activation (Sumbayev et al., 2009). As for the pathophysiology noted in the cobalt-exposed HIF1aD/D mice in their study, it would be better to select the term Th2-biased eosinophilic airway inflammation. Third, it should be interesting to clarify the correlation between HIF1a and other nuclear factors related to the Th1/Th2 response, such as T-bet and GATA-3 with or without allergic traits. To date, HIF1a reportedly positively regulates the allergic pathophysiology in vivo (Guo et al., 2009; Lee et al., 2007). However, it is possible that HIF1a plays a role in the activation of Th-related signaling dependent on the cell and/or tissue types, inflammatory stimuli, etc. Finally, regarding metal-exposed lung eosinophilia, we experienced a similar phenomenon in our in vivo study in which the acute inhalation of concentrated ambient particles (CAPs) collected in an urban city caused an increase in the number of eosinophils recovered in bronchoalveolar lavage fluids in the presence of lipopolysaccharide (LPS) compared with inhaled control air (Inoue, Hirano, Kobayashi, Takano, in preparation). LPS can biphasically lead to the Th1/Th2 condition. Furthermore, CAPs contain various metals including cobalt; accordingly, considering the study by Saini et al. (2010), this CAP-provoked lung eosinophilia related to LPS observed in our study might be caused, at least in part, by hard metals such as cobalt, probably through imbalance of the HIF pathway. Further investigation is needed to clarify this point. (...truncated)


This is a preview of a remote PDF: https://toxsci.oxfordjournals.org/content/118/1/318.full.pdf

Ken-ichiro Inoue, Masako Kiyono, Yuka Sone, Hirohisa Takano. Cobalt-Induced Lung Injury and Hypoxia-Inducible Factor 1α, Toxicological Sciences, 2010, pp. 318-318, 118/1, DOI: 10.1093/toxsci/kfq248